A prospective safety-monitoring study of immunotherapy with biologically standardized extracts.

@article{Tabar1993APS,
  title={A prospective safety-monitoring study of immunotherapy with biologically standardized extracts.},
  author={Ana Isabel Tabar and Blanca Esther Garc{\'i}a and Andrea V. Rodriguez and Jos{\'e} Mar{\'i}a Olagu{\'i}bel and Montserrat Garc{\'i}a del Muro and Santiago Quirce},
  journal={Allergy},
  year={1993},
  volume={48 6},
  pages={450-3}
}
We evaluated the safety of immunotherapy in 419 patients who attended our allergy department for treatment. They were suffering from rhinitis and asthma caused by sensitization to grass pollen or Dermatophagoides pteronyssinus. Immunotherapy was given by biologically standardized aluminum hydroxide adsorbed extracts according to a conventional schedule. Local reactions were recorded in 10.5% of the patients and systemic reactions in 4.8%. Only 0.37% of the doses administered were associated… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 27 extracted citations

Similar Papers

Loading similar papers…